Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-05-16 00:00:00 ET · period of report 2023-03-31 · accession 0001437749-23-014865 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-16 | 2023-03-31 | BLFS | DE GREEF RODERICK | Dir | M - OptEx | — | +4,740 | 44.9K | +12% | — |
| D | 2023-05-16 | 2023-03-31 | BLFS | DE GREEF RODERICK | Dir | M - OptEx | $0.00 | -4,740 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | M | A | 4,740 | — | 44,900 | D | — | — | (F1) The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 100% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date). |
| 2 | Derivative | Restricted Stock Award | 2023-03-31 | M | D | 4,740 | $0.00 | 0 | D | $0.00 · — to — | 4,740 Common Stock | (F1) The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 100% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date). |